Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib
(Q46504066)
scientific article published on 5 April 2012
scientific article published on 5 April 2012
Language: